|
EP3378926A1
|
|
A method for purifying fatty acid glycerides, compositions derived therefrom, and use thereof
|
|
WO2017050666A1
|
|
A method for purifying fatty acid glycerides, compositions derived therefrom, and use thereof
|
|
EP3273954A1
|
|
Purified compositions of polyunsaturated fatty acids, their preparation method and their use
|
|
ITUB20152896A1
|
|
Purified compositions of polyunsaturated fatty acids, their method of preparation and their use
|
|
US2014343143A1
|
|
Use of highly concentrated compositions of selected n-3 fatty acids for the treatment of central nervous system disturbances
|
|
WO2011063952A1
|
|
Formulations of bisphosphonates and vitamin d suitable for intermittent intramuscular and subcutaneous administration
|
|
US2010160435A1
|
|
Composition of n-3 fatty acids having high concentration of epa and/or dha and containing n-6 fatty acids
|
|
RS51195B
|
|
Use of highly concentrated compositions of selected n-3 fatty acids for the treatment of central nervous system disturbances
|
|
WO2005053677A1
|
|
Use of partricin derivatives for treating fungal and protozoal infections
|
|
WO2005044280A1
|
|
Biphosphonate pharmaceutical formulations (water emulsion of lipids/phospholipids) and use thereof
|
|
WO9966902A1
|
|
Injectable pharmaceutical formulations of partricin derivatives
|
|
US4372961A
|
|
Derivatives of rifamycins, their preparation and pharmaceutical compositions thereof
|
|
US3963732A
|
|
Process for preparing dihydroxydiphenylmethane derivatives
|
